B
VRTX icon

BancorpSouth’s Vertex Pharmaceuticals VRTX Stock Holding History

BancorpSouth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,925
Closed -$656K – 283
2014
Q2 		$656K Sell
6,925
-456
-6% -$32K 0.07% 122
2014
Q1 		$522K Buy
7,381
+1,660
+29% +$131K 0.06% 145
2013
Q4 		$425K Buy
5,721
+156
+3% +$10.9K 0.05% 155
2013
Q3 		$422K Buy
5,565
+62
+1% +$4.93K 0.05% 149
2013
Q2 		$441K Buy
+5,503
New +$405K 0.05% 140

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BancorpSouth's VRTX Position: Q3 2014 in Review

BancorpSouth sold out of Vertex Pharmaceuticals (VRTX) in Q3 2014, closing a stake of 6,925 shares — an estimated $656K sold.

BancorpSouth first reported a position in VRTX in Q2 2013 and held it in 5 quarters. The position peaked at $656K in Q2 2014. 430 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.

  • BancorpSouth reported no remaining Vertex Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • BancorpSouth sold 6,925 Vertex Pharmaceuticals shares in Q3 2014, an estimated $656K.
  • BancorpSouth first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • BancorpSouth's Vertex Pharmaceuticals position peaked at $656K in Q2 2014.
  • 430 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.

Based on BancorpSouth's 13F filing for Q3 2014, filed 6 Nov 2014.